Souza y MM, Quijano BEM, Reséndez R, Arroyo PF, García RL, Quintanilla BJ, Díaz BSL, Guisa CVM

Language: Spanish
References: 196
Page: 308-324
PDF size: 144.42 Kb.

ABSTRACT

In order to be whole and individualized, the therapeutic antiaddictive interventions must be based on intervention models of verified effectiveness. Experts in this field make sure that the best programs of attention provide a combination of therapies and services that cover the particular needs of every patient, in accordance with their socio-demographic variables and therapeutic precedents. The decrease of relapsing and the promotion of substantive changes in lifestyles, as result of the application of treatment models, impels to create better services in the units. Focused to make the stage of residential attention more efficient, attention models are integrated to grant services with options designed for the peculiar characteristics and needs. The enlargement and reinforcement of a program is proposed, described and documented, whose end is to make use of the structured ambiences and their social internal organization for the sake of a major number of cases, without impairment of quality. The update and renewal of the scopes of residential treatment will allow the increase of current coverage, and the operation not only of traditional methods of medical treatment, but also of new psychological techniques focused to the reduction or suppression of abuse and dependency. Facing the diversity of soliciting populations for services and the complexity accused by the proliferation of new patterns of consumption, the establishment of programs that promise feasible results, needs to be consolidated by firm steps in the handling and use of skills that support and assure the therapeutic and rehabilitation process.

REFERENCES

1. Babor TF. Alcohol and drug use history, patterns and problems. In: Rounsaville BJ, Tims FM, Horton A (eds.). Diagnostic sourcebook on drug abuse research and treatment. Rockville, MD: NIDA; 1993.

2. American Psychiatric Association, APA. Diagnostical and Statistical Manual of Mental Disorders, DSM-IV-TR. Washington: 2000.

3. Hodgins DC, El Guebaly N. More data on the addiction severity index: reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis 1992; 180: 197-201.

4. McLellan AT, Alterman AI, Metzger DS. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J Consult Clin Psychol 1994; 62: 1141-58.

5. Carroll KM, Rounsaville BJ. Implications of recent research on psychotherapy for drug abuse. In: Edwards G, Strang J, Jaffe JH (eds.). Drugs, alcohol, and tobacco. Making the Science and Policy Connections. N.Y.: Oxford Univ Press; 1993.

6. Toomey TC, Seville JL, Mann JD, Abashian SW. Relationship of sexual and physical abuse to pain description, coping, psychological distress, and health care utilization in a chronic pain sample. Clin J Pain 1996; 11: 307-15.

7. Alterman AI, McKay JR, Mulvaney FD, Cnaan A, Cacciola JS, Tourian KA, Rutherford MJ, Merikle EP. Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients. Drug Alcohol Depend 2000; 59: 215-21.

8. Booth BM, Blow FC, Cook CA. Persitence of impaired functioning and psychosocial distress after medical hospitalization for men with co-ocurring psychiatric and substance abuse disorders. J Gen Intern Med 2001; 16: 57-65.

9. Copeland A, Sorenson JL. Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 2001; 62: 91-5.

10. Carroll KM, Rounsaville BJ, Nich C. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. N.Y.: Oxford Univ Press; 2001.

11. Carroll KM. Manual guided psychosocial treatment: a new virtual requirement for pharmacotherapy trials? Arch Gen Psychiatry 2002; 23: 43-51.

12. Currie SR, Hodgins DC, Crabtree A, Jacobi J, Armstrong S. Outcome form integrated pain management treatment for recovering substance abusers. J Pain 2003; 4(2): 91-100.

13. Hoffmann N, Halikas J, Mee-Lee D. ASAM-Patient placement criteria for the treatment of psychoactive substance use disorders. Washington, DC: American Society of Addiction Medicine; 1991.

14. McCrady BS, Epstein EE. Marital therapy in the treatment of alcohol problems. In: Jacobson NS, Gurman AS (eds.). Clinical Handbook of Couples Therapy. N.Y.: Guilford; 1995, p. 369-93.

15. Souza y MM. Alcoholismo: conceptos básicos. Ed. México: Manual Moderno; 1988.

16. Anton RF, Hogan I, Jalali B. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug Alcohol Depend 1981; 8: 157-68.

17. Souza y MM. Aspectos médicos y psicológicos de la sexualidad femenina. 1a. ed. Sevilla, España: Ed. Trillas-MAD, S.L.; 2005.

18. O’Farrell TJ, Choquette KA, Cutter HSG. Behavioral marital therapy with and without additional couples relapse prevention sessions for alcoholics and their wives. J Stud Alcohol 1993; 54: 652-66.

19. Guisa CVM, Díaz BSL, Souza y MM. A propósito de la relación entre adicciones y delincuencia. Psiquiatría 2003; 19(1): 14-27.

20. Souza y MM, Rochin GG. Violencia sexual: revictimización, recidivismo y pautas para su manejo. Psiquiatría 1999; 15(2): 28-33.

21. Martínez MJ, Souza y MM. Violencia sexual y psicotrópicos. Aspectos psicodinámicos. Psiquiatría 2002; 18(1): 44-56.

22. Souza y MM. Diagnóstico y tratamiento de los síndromes adictivos. México: Ed. Ciencia y Cultura Latinoamérica; 2000.

23. Díaz BSL, Souza y MM, Romero RR, Quijano BE, Guisa CVM. Marco conceptual y consideraciones para la evaluación de programas antiadictivos. México: Dirección General Adjunta Normativa y Subdirección de Hospitalización y Proyectos Clínicos. Centros de Integración Juvenil, A. C.; 2005.

24. Souza y MM. “Adicción” al sexo, compulsión y controversia. Ginecología y Obstetricia de México 2002; 70: 477-90.

25. Gastfriend DR, McLellan AT. Treatment matching. Theoretic basis and practical implications. Med Clin North Am 1997; 81(4): 945-67.

26. Souza y MM. Por una psiquiatría de las adicciones. Rev Mex Neuroci 2003; 4(4): 206-8.

27. Souza y MM. Una mirada reflexiva a la terapéutica de las adicciones. Rev Mex Neuroci 2004; 5(6): 52-66.

28. McLellan AT, Grissom GR, Brill P. Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat 1993; 10: 243-54.

29. Guisa CVM, Díaz BSL, Souza y MM. Terapéutica antiadictiva: utilidad de sus factores de predicción. Rev Mex Neuroci 2004; 5(6): 581-98.

30. Ciraulo DA, Piechniczek-Buczek J, Nalan IE. Outcome predictors in substance use disorders. Psychiat Clin North Am 2003; 26(2): 36-72.

31. Souza y MM. Programa profesional terapéutico contra las adicciones. Una propuesta integrativa. Psiquiatría 2005; 21(1): 25-37.

32. Souza y MM. Consideraciones y fundamentos para una terapéutica profesional de las adicciones. Rev Mex Neuroci 2003; 4(5): 326-30.

33. Souza y MM. Dos palabras sobre la terapéutica actual de las adicciones. Liber@ddictus; 2004, p. 12-20.

34. Souza y MM, Martínez AJ, Martínez MJ, Mercado CG, Tagle OI. Craving, adicción etílica y terapéutica. Arch Neuroci Méx 2000; 5(4): 201-4.

35. Markianos M, Lykouras L, Moussas G, Hatzimanolis J. Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse. Drug Alcohol Depend 2001; 64: 363-5.

36. Monterosso JR, Flannery BA, Pettinati HM. Predicting treatment response in naltrexone: the influence of craving and family history. Am J Addict 2001; 10: 258-68.

37. Souza y MM. Nosología y terapéutica de los programas contra las adicciones. Rev Mex Neuroci 2005; 6(2): 166-79.

38. Bauer LO. Predicting relapse to alcohol and drug abuse via quantitative electro-encephalography. Neuropsycho-pharmacology 2001; 25: 332-40.

39. Litt MD, Cooney NL, Morse P. Reactivity to alcohol-related stimuli in the laboratory and in the field: predictors of craving in treated alcoholics. Addiction 2000; 9(5): 889-900.

40. Rohsenow DJ, Monti PM. Does urge to drink predict relapse after treatment? Alcohol Research and Health 1999; 23: 225-32.

41. Miller WR, Westerberg VS, Harris RJ, Tonigan JS. What predicts relapse? Prospective testing of antecedent models. Addiction 1996; 91: S155-S172.

42. Vielva I, Iraurgi I. Cognitive and behavioural factors as predictors of abstinence following treatment for alcohol dependence. Addiction 2001; 96: 297-303.

43. Kampman KM, Alterman AI, Volpicelli JR, Maany I, Muller ES, Luce DD. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav 2001; 15: 52-9.

44. Reiber C, Ramirez A, Parent D, Rawson RA. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug Alcohol Depend 2002; 68: 35-48.

45. McMahon RC, Malow R, Loewinger L. Substance abuse history predicts depression and relapse status among cocaine abusers. Am J Addict 1999; 8: 1-8.

46. Hartz DT, Frederick-Osborne SL, Galloway GP. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend 2001; 63: 269-76.

47. Brewer DD, Fleming CB, Haggerty KP, Catalano RF. Drug use predictors of partner violence in opiate-dependent women. Violence Vict 1998; 13: 107-15.

48. Avants SK, Margolin A, McKee S. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program. J Subst Abuse 2000; 11: 215-30.

49. Killen JD, Fortmann SP, Kraemer HC, Varady A, Newman B. Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol 1992; 60: 797-801.

50. Kadden RM, Cooney NL, Getter H. Matching alcoholics to coping skills or interactional therapies: posttreatment results. J Consult Clin Psychol 1989; 57: 698-704.

51. McLachlan J. Benefit from group therapy as a function of patient-therapy match on conceptual level. Psychother Res Pract 1972; 9: 317-23.

52. McLellan AT, O’Brien CP, Kron R. Matching substance abuse patients to appropriate treatments: a conceptual-methodological approach. Drug Alcohol Depend 1980; 5: 189-95.

53. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: project MATCH posttreatment drinking outcomes Part I. J Stud Alcohol 1997; 58: 7-29.

54. Center for substance abuse treatment. The role and current status of patient placement criteria in the treatment of substance use disorders. Treatment improvement protocol (TIP). Series 13. Rockville, MD: Substance Abuse and Mental Health Services Administration; 1995.

55. Normand J, Lempert RO, O’Brien CP (eds.). Under the influence? Drugs and the American Committee on Drug Use in the Workplace. Washington, DC: National Academy Press; 1994.

56. Rockett IRH, Putnam SL, Jia H, Smith GS. Assessing substance abuse treatment need: a statewide hospital emergency department study. Annals of Emergency Medicine 2003; 41(6): 802-13.

57. Bernstein E, Bernstein J, D’Onofrio G. Patients who abuse alcohol and other drugs: emergency department identification, intervention, and referral. In: Tintinalli JE, Kelen GD, Stapczynski JS (eds.). Emergency Medicine: a comprehensive study guide. 5th ed. N.Y.: McGraw Hill; 1999.

58. Laine C, Hauck WW, Gourevitch MN. Regular outpatient medical and drug abuse care and subsequent hospi-talization of persons who use illicit drugs. JAMA 2001; 285: 2355-62.

59. Center for substance abuse treatment. Enhancing motivation for change in substance abuse treatment. Treatment improvement protocol (TIP) Series 35. Rockville, MD: Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1999. DHHS Publication No. (SMA) 99-3354.

60. Souza y MM, Guisa CVM, Díaz BSL. Hacia una integración nacional de la terapéutica antiadictiva. México: Subdirección de Hospitalización y Proyectos Clínicos. Centros de Integración Juvenil, A.C.; 2005.

61. Miller NS, Ninonuevo FG, Klamen DL, Hoffman NG. Integration of treatment and posttreatment variables in predicting results of abstinence-based outpatient treatment after one year. J Psychoactive Drugs 1997; 29(3): 239-48.

62. Annis H. Patient-treatment matching in the management of alcoholism. NIDA Res Monogr 1988; 90: 152-61.

63. Project MATCH Research Group. Matching alcohol treatments to client heterogeneity: posttreatment drinking outcomes Part II. J Stud Alcohol 1997; 59: 35-43.

64. Miller WR, Zweben A, DiClemente CC. Motivational enhancement therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. NIAAA Project MATCH Monograph Series Vol. 2. DHHS Publication No. (ADM) 92-1894. Rockville, MD: NIAAA; 1992.

65. Hser Y. A referral system that matches drug users to treatment programs: existing research and relevant issues. J Drug Issues 1995; 25: 209-24.

66. US Preventive Services Task Force. Mental disorders and substance abuse. Screening for drug abuse. In: Guide to clinical preventive services. 2nd ed. Available at: http://cpmcnet.columbia.edu/texts/gcps/gcps0063.html. Accessed October 11, 2001.

67. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 1999 Emergency Department Summary. Advance Data from Vital and Health Statistics; No. 320. Hyattsville, MD: National Center for Health Statistics; 2001.

68. D’Onofrio G; Degutis LC. Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review. Acad Emerg Med 2002; 9: 627-38.

69. Souza y MM. Análisis observacional de la constelación adicto-terapéutica. Simposio Personalidad y Adicciones. Sección Académica de Farmacodependencia y Alcoholismo Congreso Regional Vicepresidencia Noroeste “Trastornos de la personalidad y su comorbilidad”. Asociación Psiquiátrica Mexicana, A.C. San Carlos, Mpo. Guaymas, Sonora. 3-6 de junio, 2004.

70. Bachman S, Batten H, Minkoff K. Predicting success in a community treatment program for substance abusers. Clin Update Series 1992; 1: 155-67.

71. Mee-Lee D, Hoffmann NG. LOCI-Level of care index: a concise summary of ASAM criteria’s factors to document for placement, continued stay, and discharge. St Paul, MN: New Standards; 1992.

72. Book J, Jarbin H, Marques C. The ASAM and Green spring alcohol and drug detoxification and rehabilitation criteria for utilization review. Am J Addict 1995; 4: 187-97.

73. Babor TF, Longabaugh R, Zweben A. Issues in the definition and measurement of drinking outcomes in alcoholism treatment research. J Stud Alcohol 1994; 12(Suppl.): 101-11.

74. Barry KL. Consensus Panel. Brief interventions and brief therapies for substance abuse. Treatment improvement protocol (TIP) Series 34. Rockville, MD: Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1999. DHHS Publication No. (SMA) 99-3353.

75. Carroll KM, Rounsaville BJ, Nich C. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51: 989-97.

76. Carroll KM, Rounsaville BJ. Implications of recent research on psychotherapy for drug abuse. In: Edwards G, Strang J, Jaffe JH (eds.). Drugs, alcohol, and tobacco: Making the science and policy connections. New York: Oxford University Press; 1993.

77. Carroll KM. Relapse prevention as a psychosocial treatment approach: a review of controlled clinical trials. Exp Clin Psychopharmacol 1996; 4: 46-54.

78. Carroll KM, Power MD, Bryant KJ, Rounsaville BJ. One year follow-up status of treatment-seeking cocaine abusers psychopathology and dependent severity as predictors of outcome. J Nerv Ment Dis 1993; 181: 71-9.

79. Finney JW, Keller DS, Dermatis H, Egelko S. The impact of managed care on substance abuse treatment: a report of The American Society Addiction Medicine. 2000; 19: 13-34.

80. Friedman PD, Lemmon SC, Anderson BJ, Stein MD. Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug Alcohol Dependence; 2003, p. 243-51.

81. Fudala PJ, Berkow LC, Fralich JL. Use of naloxone in the assessment of opiate dependence. Life Sci 1991; 49: 1809-14.

82. Galanter M. Network therapy for and drug abuse: a new approach in practice. New York: Basic Books; 1993.

83. Carroll KM, Rounsaville BJ, Gordon L, Nich C, Jatlow P, Bisighini RM, Gawin FM. Psychotherapy and pharmaco-therapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51: 177-87.

84. PNUFID. Por qué invertir en el tratamiento del abuso de drogas: documento debate para la formulación de políticas. Oficina de las Naciones Unidas Contra la Droga y el Delito. Nueva York: 2003.

85. Puchol ED. Trastornos adictivos (I): principios clave del tratamiento. Revista de psicología www. hispavista. com 2005.

86. Alterman AI, McKay JR, Mulvaney FD, McLellan AT. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine dependent men. Drug Alcohol Depend 1996; 40: 227-33.

87. Carroll KM, Rounsaville BJ, Gawin FH. A comparative trial of psychotherapies for ambulatory cocaine abusers relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse 1991; 17: 229-47.

88. Morey LC. Patient placement criteria: Linking typologies to managed care. Alc Health and Research World 1996; 20: 36-44.

89. Chase Ch. Patient placement criteria for the treatment of substance-related disorders. American Society of Addiction Medicine, Inc; 1996, p. 205.

90. Mulvaney F, Alterman AI, Boardman CR, Kampman KM. Cocaine abstinence symptomatology and treatment attrition. J Subst Abuse Treat 1999; 16: 129-35.

91. Hser Y, Joshi V, Anglin MD, Fletcher B. Predicting posttreatment cocaine abstinence for first-time admissions and treatment repeaters. Am J Public Health 1999; 89(5): 666-71.

92. National Center for Chronic Disease Prevention and Health Promotion. Behavioral Risk Factor Surveillance System. October 18, 2001.

93. Green CA, Polen MR, Dickinson MD, Lynch FL, Bennett MD. Gender differences in predictions of initiation, retention and completion in a HMO-based substance abuse treatment program. J Subst Abuse Treat 2002; 23: 285-95.

94. O’Malley SS, Jaffe AJ, Chang G. Six month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996; 53: 217-24.

95. Portenoy RK. Opiate therapy for chronic nonmali-gnant pain. Pain research and management 1996; 1: 17-28.

96. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychologist 1992; 47: 1102-14.

97. Project MATCH Research Group: Project MATCH: Rationale and methods for a multisite clinical trial matching alcoholism patients to treatment. Alcohol Clin Exp Res 1993; 17: 1130-45.

98. Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W. Methamphetamine and cocaine users differences in characteristics and treatment retention. J Psychoactive Drugs 2000; 32: 233-8.

99. Rounsaville BJ. Can psychotherapy rescue naltrexone treatment of opioid addiction? In: Onken LS, Blaine JD (eds.). Potentiating the efficacy of medications: integrating psychosocial therapies with pharmaco-therapies in the treatment of drug dependence. NIDA Research Monograph Series Number 105. Rockville, MD: NIDA; 1995, p. 37-52.

100. Sattar SP, Petty F, Burke WJ. Diagnosis and treatment of alcohol dependence in older alcoholics. Clin Geriat Med 2003; 19(4): 1-17.

101. Schneider Institute for Health Policy. Substance abuse: the nation’s number one health problem. Waltham, MA: Schneider Institute for Health Policy; 2001.

102. Shwartz M, Mulvey KP, Woods D, Brannigan P, Plough A. Length of stay as an outcome predictor in an era of managed care. An empirical study. J Subst Abuse 1997; 14: 11-18.

103. Silverman K, Higgins ST, Brooner RK. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996; 53: 409-15.

104. Simpson DD, Jos GW, Broome KM. A National 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiat 2002; 59: 538-44.

105. Timko C, Moos RH, Finney JW, Connell EG. Gender differences in help-utilization and the 8-year course of alcohol abuse. Addiction 2002; 97: 887-9.

106. Timko C, Moos RH, Finney JW, Lessar MD. Long-term outcomes of alcohol use disorders: comparing untreated individuals with those in alcoholics anonymous. J Stud Alcohol 2000; 61: 529-40.

107. US Department of Health and Human Services. Healthy people 2010: understanding and improving health. Section 26-22. 2nd ed. Washington, DC: US Government Printing Office; 2000.

108. Vaslamatzis G, Katsouyanni K, Markidis M. The efficacy of a psychiatric halfway house: a study of hospital recidivism and global outcome measure. Eur Psychiatric. 1997; 12: 94-7.

109. Walker JM, Strangman NM, Huang SM. Cannabinoids and pain, Pain Research and Management 2002; 6: 74-91.

110. Weisner C, Ray RG, Mertens JR, Satre DD, Moore CH. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol and Depence 2003; 71: 281-94.

111. Weisner C, Schmidt L. Rethinking access to alcohol treatment. Recent Dev Alcohol 2001; 15: 107-36.

112. Ministerio de Salud, Unidad de Salud Mental. Plan Nacional de Salud Mental y Psiquiatría. Santiago de Chile: Enero; 2000.

113. Orientaciones técnicas para el funcionamiento de hospitales de día en psiquiatría. Ministerio de Salud. Santiago de Chile: Noviembre; 2001.

114. Olivos P y cols. Evaluación de la efectividad del Hospital Diurno del Hospital Psiquiátrico de Santiago. Rev Chil Neuropsiquiat 1982; 20: 119-25.

115. Pang J. Partial hospitalization: an alternative to impatient care. Psychiat Clin North Am 1985; VIII(3): 587-95.

116. Gomberoff L, Olivos P. Hospitalización diurna en Psiquiatría. En: Manual de Psiquiatría. Cap. 14. Santiago de Chile: Publicaciones Técnicas Mediterráneo; 1986.

117. Horwitz-Lennon M, Sharon-Lise TN, Gaccione P, Frank R. Partial versus full hospitalization for adults in psichiatric distress: a systematic review of the published literature (1957-1997). Am J Psychiatry 2001; 158: 676-85.

118. Olivos P. El Hospital Diurno como organización. Rev Psiquiat 1986; III(10-11): 233-8.

119. Olivos P. El Centro Psiquiátrico Irarrázabal, una estructura en la comunidad para el apoyo y tratamiento del paciente psiquiátrico crónico. Rev Psiquiat 1989; VI: 35-40.

120. Silva H, Jerez S y cols. Estructura y funcionamiento del Hospital Diurno de la Clínica Psiquiátrica Universitaria. Rev Psiquiat Clin 1987; 26(1): 55-62.

121. Grupo de Trabajo URAs de Andalucía. La Unidad de Rehabilitación de Área: URA. Mimeo. Servicio Andaluz de Salud, Andalucía, España: Octubre-Noviembre de 1999.

122. Meltzoff J, Blumenthal RL. The day treatment center: principles, application and evaluation. Springfield, IL: Charles C Thomas; 1966.

123. Creed F, et al. Randomized controlled trial of day patient versus inpatient psychiatric treatment. BMJ 1990; 300: 1033-7.

124. Dick P, et al. Day and full time psychiatric treatment: a controlled comparison. Brit J Psychiat 1985; 147: 246-9.

125. Schene AH, et al. The utrecht comparative study on psychiatric day treatment and inpatient treatment. Acta Psychiatrica Scandinavica 1993; 87: 427-36.

126. Rakfeldt J, Tebes J, Steiner JDO, Walter P, Davidson L, Sledge W. Normalizing acute care: a day hospital/crisis residence alternative to inpatient hospitalization. J Nervous and Mental Disease 1997; 185(1): 46-52.

127. Crisp A, Gelder MG, Goddard E, Meltzer H. Estigmatización de las personas que sufren enfermedades mentales: un estudio de seguimiento del Royal College of Psychiatrists en el contexto de la campaña “Cambiemos nuestras mentes”. World Psychiatry 2005: 3(2): 36-46.

128. Marshall M. How effective are different types of day care services for people with severe mental disorders? WHO Regional Office for Europe’s Health Evidence Network (HEN). World Health Organization, Copenhagen, Denmark; 2005.

129. Souza y MM. El papel de la mitología popular, la semántica y la iatrogenia en las adicciones. Rev Mex Neuroc 2001; 2(1): 25-7.

130. Guisa CVM, Díaz BSL, Souza y MM. Adicción, normatividad y terapéutica. Psiquiatría 2004; 20(3): 25-37.

131. Proyecto de Norma Oficial Mexicana NOM-168-SSA1-1998 del Expediente Clínico. Diario Oficial. Ciudad de México, lunes 7 de diciembre de 1998.

132. Norma Oficial Mexicana NOM-025-SSA2-1994 para la prestación de servicios de salud en unidades de atención integral hospitalaria médico-psiquiátrica. Diario Oficial. Ciudad de México, miércoles 15 de noviembre de 1995.

133. Norma Oficial Mexicana NOM 028-SSA2-1999 para la prevención, tratamiento y control de las adicciones. Diario Oficial. Ciudad de México, viernes 18 de agosto de 2000.

134. Hospital Universitario San Cecilio de Granada. Área Salud Mental Granada Sur. Unidad de Rehabilitación de Área (URA). Cartera de Servicios. Mimeo. Servicio Andaluz de Salud, Granada, España, enero de 1998.

135. Olivos P. Historia de los hospitales diurnos. Rev Psiquiat 1985; II: 23-7.

136. Olivos P. Taller sobre instituciones intermedias en la rehabilitación. Rev Psiquiat 1985; I: 129-31.

137. Olivos P. El hospital diurno como organización. Rev Psiquiat 1986; (10-11): 233-8.

138. Equipo hospital de día servicio de psiquiatría, Hospital Barros Luco-Trudeau. Resumen de la primera jornada de evaluación y planificación del hospital de día del servicio de psiquiatría del Hospital Barros Luco-Trudeau. Mimeo. Santiago de Chile, enero 2001.

139. Aguirre R. Rol del terapeuta ocupacional en los hospitales de día. Mimeo, Santiago de Chile, febrero 2001.

140. Kazdin AE. Methods of psychotherapy research. In: Bongar B, Beutler LE (eds.). Comprehensive textbook of psychotherapy: theory and practice. N.Y.: Oxford University Press; 1995.

141. Rounsaville BJ, Carroll KM. Interpersonal psychotherapy for drug users. In: Klerman GL, Weissman MM (eds.). New applications of interpersonal psychotherapy. Washington, DC: American Psychiatric Association Press; 1993.

142. Luborsky L, DeRubeis RJ. The use of psychotherapy treatment manuals: a small revolution in psychothera-py research style. Clin Psychol 1984; 4: 5-15.

143. Rounsaville BJ, Carroll K. Individual psychotherapy for drug abusers. In: Lowinsohn JH, Ruiz P, Millman RB (eds.). Comprehensive textbook of substance abuse. 2nd ed. Baltimore: Williams & Wilkins; 1992.

144. Souza y MM, Mercado CG, Martínez AJ, Arciniéga TA, Solís RL y col. Paquete de material educativo para la capacitación en adicciones del personal de salud. Subdirección de Investigación y Adicciones. Fideicomiso para los institutos de niños de la calle y las adicciones, FINCA. México: Gobierno del Distrito Federal; 2000.

145. Marshall M. Day hospital versus admission for acute psychiatric disorders. The Cochrane Library; 2003, p. 4.

146. World Health Organization. World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva, 2001, http://www.who.int/whr2001/2001/main/en/.

147. Zwerling I, Wilder JF. An evaluation of the applicability of the day hospital in the treatment of acutely disturbed patients. Israel Ann Psychiatry and Related Disciplines 1964; 2: 162-85.

148. Beard JH, et al. Evaluating the effectiveness of a psychiatric rehabilitation program. Am J Orthopsychiatry 2003; 33: 701-12.

149. Crowther R. Vocational rehabilitation for people with severe mental illness. The Cochrane Library; 2003, p. 4.

150. Sledge WH. Day hospital/crisis respite care versus inpatient care. Part I. Clinical outcomes. Am J Psychiatry 1996, 153: 1065-73.

151. Kiejna A, Kallert TW, Rymaszewska J. Treatment in psychiatric day hospital in comparison with inpatient wards in different European health care systems-objectives of EDEN project. Psychiatria Polska 2002; 36(Suppl. 6): 361-7.

152. Weldon E, et al. Day hospital versus outpatient treatment: a controlled study. Psychiatric Quarterly 1979; 51: 144-50.

153. Marshall M. Acute psychiatric day hospitals. BMJ 2003; 327: 116-17.

154. Herz MI. et al. Day versus inpatient hospitalization: a controlled study. Am J Psychiatry 1971; 10: 1371-82.

155. Kris EB. Day hospitals. Current Therapeutic Research 1965; 7: 320-3.

156. Johnstone P, Zolese G. Length of hospitalization for people with severe mental illness. The Cochrane Library; 2003, p. 4.

157. Herz MI, Endicott J, Spitzer RL. Brief hospitalization of patients with families: initial results. Am J Psychiatry 1975; 132: 413-18.

158. Hirsch SR. Shortening hospital stay for psychiatric care: effect on patients and their families. BMJ 1979; 1: 442-6.

159. Dush DM. Reducing psychiatric hospital use of the rural poor through intensive transitional acute care. Psychiatric Rehabilitation J 2001; 25(1): 28-34.

160. Marshall M, et al. Day hospital versus outpatient care for psychiatric disorders. The Cochrane Library; 2003.

161. Glick ID, et al. A controlled study of transitional day care for non-chronically ill patients. Am J Psychiat 1986; 143: 1551-6.

162. Dincin J, Witheridge TF. Psychiatric rehabilitation as a deterrent to recidivism. Hosp Comm Psychiatry 1982; 33(8): 645-50.

163. Ball J, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag; 1991.

164. McLellan AT, Grissom GR, Brill P. Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat 1993; 10: 243-54.

165. Mueser KT, Becker DR, Wolfe R. Supported employment, job preferences, job tenure and satisfaction. J Ment Health 2001; 10: 411-17.

166. Lehman AF, et al. Improving employment outcomes for persons with severe mental illnesses. Arch Gen Psychiatry 2002; 59(2): 165-72.

167. Catty J, Burns T, Comas A. Day centres for severe mental illness. The Cochrane Library; 2003, p. 4.

168. McFarlane WR, et al. Employment outcomes in family-aided assertive community treatment. Am J Orthopsy-chiatry 2000; 70(2): 203-14.

169. Meisler N. Rural-based supported employment approa-ches: results from the South Carolina site of the employment intervention demonstration project. 155th Philadelphia: Annual Meeting of the American Psychiatric Association, 18-23 May 2002.

170. McLellan A, Luborsky L, Cacciola J. New data from the Addiction Severity Index-reliability and validity in three centers. J Nerv Mental Dis 1985; 173: 412-23.

171. Joe GW, Simpson DD, Hubbard RL. Treatment predictors of tenure in methadone maintenance. J Subst Abuse 1991; 3: 73-84.

172. DiClemente CC, Carroll KMm, Connors GJ. Process assessment in treatment matching research. J Stud Alcohol 1994; 12: 156-62.

173. Miller WR, Cooney NL. Designing studies to investigate client-treatment matching. J Stud Alcohol 1994; (Suppl.)12: 38-45.

174. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity Project MATCH posttreatment drinking longterm outcom. J Stud Alcohol 1999; 73: 53-64.

175. Creed F. Cost effectiveness of day and in-patient psychiatric treatment. BMJ 1997; 314: 1381-5.

176. Reglamento de la Ley General de Salud en Materia de Prestación de Servicios de Atención Médica, Diario Oficial de la Federación, México, 14 de mayo de 1986.

177. Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. Diario Oficial de la Federación, México, 6 de enero de 1987.

178. Diario Oficial. NOM-001-SSA1-1993. Que instituye el procedimiento por el cual se revisará, actualizará y editará la Farmacopea de los Estados Unidos Mexicanos.

179. Diario Oficial. NOM-025-SSA2-1994. Para la prestación de servicios de salud en unidades de atención integral hospitalaria médico-psiquiátrica. 16 de noviembre de 1995.

180. Diario Oficial. NOM-010-SSA2-1993. Para la prevención y control de la infección por virus de la inmunodeficiencia humana y Modificación de fecha 22 de junio de 2000.

181. Diario Oficial. NOM-009-SSA2-1993. Para el fomento de la salud del escolar. 4 de Octubre, 1994.

182. Diario Oficial. NOM-017-SSA2-1994. Para la vigilancia epidemiológica. 12 de octubre, 1999.

183. Diario Oficial. NOM-168-SSA1-1998. Del expediente clínico y modificación de fecha 22 de agosto de 2003. 1 de octubre, 1999.

184. Diario Oficial. NOM-039-SSA2-2002. Para la prevención y control de las infecciones de transmisión sexual.

185. Diario Oficial. NOM-013-SSA2-1994. Para la prevención y control de enfermedades bucales y modificación de fecha 21 de enero de 1999.

186. Diario Oficial. NOM-003-SSA2-1993. Para la disposición de sangre humana y sus componentes con fines terapéuticos.

187. Centros de Integración Juvenil, A. C. Alternativas de Rehabilitación en Salud Mental. Vol. 14. México: CIJ; 1996.

188. Guisa CVM, Díaz BSL, Sánchez HR, Souza y MM. Farmacoterapia de los síndromes de intoxicación y abstinencia por psicotrópicos. México: Centros de Integración Juvenil; 2003.

189. Guía técnica de atención curativa. Dirección de Tratamiento y Rehabilitación. México: Centros de Integración Juvenil, A.C.; 2005.

190. Alterman AI, Kampman K, Boardman CR, Cacciola JS, Rutherford MJ, McKay JR. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend 1997; 46(1-2): 79-85.

191. Annis H. Patient-treatment matching in the management of alcoholism. NIDA Res Monogr 1988; 90: 152-61.

192. Bachman S, Batten H, Minkoff K. Predicting success in a community treatment program for substance abusers. Clin Update Series 1992; 1: 155-67.

193. Book J, Jarbin H, Marques C. The ASAM and Green Spring alcohol and drug detoxification and rehabilitation criteria for utilization review. Am J Addict 1995; 4: 187-97.

194. Hoffmann N, Halikas J, Mee-Lee D. ASAM-Patient Placement criteria for the treatment of psychoactive substance use disorders. Washington, DC: American Society of Addiction Medicine; 1991.

195. Souza y MM. Enseñanza e investigación sobre adicciones en la Ciudad de México. Psiquiatría 1998; 14(3): 100-6.

196. Tagle OI, Mercado CG, Martínez AJ, Martínez MJ, Souza y MM. Por qué profesionalizar la terapéutica de las adicciones. Psiquiatría 2000; 16(3): 110-16.